Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 9564 record(s)

Req # A-2024-000012

Adverse Drug Reactions (ADRs). Report numbers: 001067949, 001069982.

Organization: Health Canada

17 page(s)
April 2024

Req # A-2024-000017

Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number: 1026516, 1043922. ADRs for HYDROXYCHLOROQUINE. Report numbers: 1024918, 1026702, 1037377.

Organization: Health Canada

70 page(s)
April 2024

Req # A-2024-000028

Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.

Organization: Health Canada

29 page(s)
April 2024

Req # A-2024-000032

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.

Organization: Health Canada

76 page(s)
April 2024

Req # A-2024-000068

Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.

Organization: Health Canada

3 page(s)
April 2024

Req # A-2023-00208

A legible copy of the site survey included at Annex A of the NCC approval document for the disposition of 6556 County Rd 29, Mississippi Mills, File #CP2263-259, IAMIS #14056, as well as any other documents pertaining to this site.

Organization: National Capital Commission

128 page(s)
April 2024

Req # A-2024-00006

Please provide any photos showing the interior of 24 Sussex after the recent work on asbestos, wiring and plumbing since September 1st, 2023.

Organization: National Capital Commission

133 page(s)
April 2024

Req # A-2024-00020

Provide the total amount the NCC spent purchasing the property at 47-57 Rideau St. Please also provide any projected expenditures related to planned renovations at the site.

Organization: National Capital Commission

26 page(s)
April 2024

Req # A-2024-00032

All documents, including internal communications, relating to the installation of a fence on the grounds of Stornoway. Please limit search to documents from January 1, 2023 to December 31, 2023.

Organization: National Capital Commission

67 page(s)
April 2024

Req # A-2024-00039

Provide documents showing who received the Signal messages tabled at the Public Order Emergency Commission (Signal is a messaging app with end-to-end encryption).

Organization: National Capital Commission

0 page(s)
April 2024
Date modified: